Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial (Q28222007)

1

0 references

Marcia Irene Canto

2

0 references

Elizabeth Montgomery

4

0 references

Wilfred M Weinstein

5

0 references

James G Herman

6

0 references

Andrew J Dannenberg

7

0 references

Vincent W Yang

8

0 references

Albert O Shar

9

0 references

Ernest Hawk

10

0 references

Arlene A Forastiere

Journal of the National Cancer Institute

11

0 references

language of work or name

English

0 references

publication date

4 April 2007

0 references

published in

0 references

volume

99

0 references

issue

7

0 references

page(s)

545-57

0 references

cites work

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Chemoprevention for Barrett's esophagus trial. Design and outcome measures

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Mortality study of 18 000 patients treated with omeprazole.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Indications for antireflux surgery in Barrett's.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Standard resection for cancer of the esophagus and cardia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Aspirin use and risk of fatal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Management of adenocarcinoma arising in Barrett's esophagus

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors.

2 June 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK112

Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK112

Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK112

Quantitative endoscopy: precise computerized measurement of metaplastic epithelial surface area in Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJK112

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3755596

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus

27 November 2018

1 reference

12 December 2020

Observer variation in the diagnosis of dysplasia in Barrett's esophagus

1 reference

12 December 2020

Aspirin and reduced risk of esophageal carcinoma

1 reference

12 December 2020

The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years

1 reference

12 December 2020

Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus

1 reference

12 December 2020

Extent of Barrett's metaplasia: a prospective study of the serial change in area of Barrett's measured by quantitative endoscopic imaging

1 reference

12 December 2020

Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJK112

1 reference

release_g3jesryizjha7lkiubiyye5s5u

4527300

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g3jesryizjha7lkiubiyye5s5u

24 November 2022

mapped directly with Wikidata item

4527300

1 reference

1 reference

1 reference